{
    "ticker": "BNAI",
    "name": "BioNano Genomics, Inc.",
    "description": "BioNano Genomics, Inc. is a biotechnology company that specializes in genomic analysis and precise genome mapping. Founded in 2003 and headquartered in San Diego, California, BioNano aims to revolutionize the field of genomics by providing advanced tools for genetic research and diagnostics. The company\u2019s flagship product, the Saphyr system, leverages proprietary optical mapping technology to deliver high-resolution structural variation and genome assembly data, enabling researchers and clinicians to better understand complex genomic disorders. BioNano's technology is particularly valuable in fields such as cancer research, genetic disease analysis, and prenatal testing. By offering a comprehensive platform for genomic analysis, BioNano enhances the ability of scientists and healthcare professionals to make informed decisions regarding patient care and research outcomes. The company's mission is to improve patient lives through genomic insights and to empower laboratories worldwide with cutting-edge technology that transforms genomic research into actionable knowledge. BioNano continues to innovate, focusing on expanding its applications in clinical settings and driving advancements in personalized medicine.",
    "industry": [
        "Biotechnology",
        "Genomics"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2003",
    "website": "https://www.bionanogenomics.com",
    "ceo": "Erik Holmlin",
    "social_media": {
        "twitter": "https://twitter.com/BioNanoGenomics",
        "linkedin": "https://www.linkedin.com/company/bionanogenomics/"
    },
    "investor_relations": "https://investors.bionanogenomics.com",
    "key_executives": [
        {
            "name": "Erik Holmlin",
            "position": "CEO"
        },
        {
            "name": "David E. Eberle",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Genomic Analysis",
            "products": [
                "Saphyr System",
                "Optical Mapping Software"
            ]
        }
    ],
    "seo": {
        "meta_title": "BioNano Genomics, Inc. | Advanced Genomic Analysis Solutions",
        "meta_description": "Explore BioNano Genomics, Inc., a leader in genomic analysis, offering innovative solutions for precise genome mapping and structural variation detection.",
        "keywords": [
            "BioNano Genomics",
            "Genomic Analysis",
            "Genome Mapping",
            "Saphyr",
            "Optical Mapping",
            "Personalized Medicine"
        ]
    },
    "faq": [
        {
            "question": "What does BioNano Genomics specialize in?",
            "answer": "BioNano Genomics specializes in genomic analysis and precise genome mapping."
        },
        {
            "question": "What is the Saphyr system?",
            "answer": "The Saphyr system is an advanced platform for high-resolution structural variation and genome assembly analysis."
        },
        {
            "question": "Where is BioNano Genomics located?",
            "answer": "BioNano Genomics is headquartered in San Diego, California, USA."
        },
        {
            "question": "Who is the CEO of BioNano Genomics?",
            "answer": "Erik Holmlin is the CEO of BioNano Genomics, Inc."
        },
        {
            "question": "When was BioNano Genomics founded?",
            "answer": "BioNano Genomics was founded in 2003."
        }
    ],
    "competitors": [
        "PACB",
        "ILMN",
        "NGEN",
        "MCRB"
    ],
    "related_stocks": [
        "EXAS",
        "EDIT",
        "CRSP",
        "SGEN"
    ]
}